AARDEX and Cambridge Cognition Partner to Improve Adherence in DCTs


AARDEX Group and Cambridge Cognition have teamed up to improve adherence monitoring during hybrid and DCTs. AARDEX Group’s MEMS® dosing capture and analytics system will be intergrated with Cambridge Cognition’s Clinpal DCT platform providing sponsors and CROs with a new adherence management tool.

Read more about the partnership here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.